Parsa C
J Ophthalmic Vis Res. 2025; 19(4):392-396.
PMID: 39917451
PMC: 11795007.
DOI: 10.18502/jovr.v19i4.17786.
Wienerroither B, Mylonas G, Bernhart C, Prager F, Kahraman G, Amon M
J Clin Med. 2024; 13(22).
PMID: 39597926
PMC: 11594931.
DOI: 10.3390/jcm13226781.
Lin Y, Xie B, Ke S, Ye W, Huang D, Chen W
BMC Ophthalmol. 2024; 24(1):428.
PMID: 39354377
PMC: 11443798.
DOI: 10.1186/s12886-024-03693-2.
Gangaputra S, Newcomb C, Ying G, Groth S, Fitzgerald T, Artornsombudh P
Am J Ophthalmol. 2024; 267:182-191.
PMID: 38880375
PMC: 11486591.
DOI: 10.1016/j.ajo.2024.06.006.
Souissi S, Allou V, Trucchi L, Le Mer Y, Tadayoni R, Couturier A
Eye (Lond). 2023; 38(6):1155-1161.
PMID: 38040966
PMC: 11009244.
DOI: 10.1038/s41433-023-02852-x.
Corticosteroid-Antibiotic Interactions in Bacteria that Cause Corneal Infection.
Lee H, Kim S, Rahaman M, Kang D, Kim C, Kim T
Transl Vis Sci Technol. 2023; 12(5):16.
PMID: 37184498
PMC: 10187793.
DOI: 10.1167/tvst.12.5.16.
Safety of the bag-in-the-lens implantation regarding the development of clinically significant pseudophakic cystoid macular edema: A retrospective case series study.
Scheers D, Rens J, Van Os L, Dhubhghaill S, De Groot V, Kiekens S
PLoS One. 2023; 18(1):e0278861.
PMID: 36607976
PMC: 9821458.
DOI: 10.1371/journal.pone.0278861.
The impact of surgeon's experience and sex on the incidence of cystoid macular edema after uneventful cataract surgery.
List W, Steinwender G, Glatz W, Riedl R, Wedrich A, Ivastinovic D
PLoS One. 2022; 17(12):e0279518.
PMID: 36574394
PMC: 9794095.
DOI: 10.1371/journal.pone.0279518.
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Wingert A, Liu S, Lin J, Sridhar J
Cochrane Database Syst Rev. 2022; 12:CD004239.
PMID: 36520144
PMC: 9754896.
DOI: 10.1002/14651858.CD004239.pub4.
Central macular thickness change after uneventful small-incision cataract surgery - An observational study.
Dabas G, Shukla P, Mithal K, Bhartiya S, Singh V, Agarwal S
Indian J Ophthalmol. 2022; 70(11):3995-3999.
PMID: 36308142
PMC: 9907309.
DOI: 10.4103/ijo.IJO_793_22.
Simultaneous existence of three intraocular lens inside one eye.
Mei F, Kao T, Cheng C
Taiwan J Ophthalmol. 2022; 12(2):209-212.
PMID: 35813795
PMC: 9262020.
DOI: 10.4103/tjo.tjo_29_21.
Incidence of Pseudophakic Cystoid Macular Oedema Post-Cataract Surgery in Illawarra Shoalhaven Local Health District, Australia.
Seth I, Bulloch G, Tan A, Thornell E, Agarwal S
Biomed Hub. 2022; 7(1):1-10.
PMID: 35223872
PMC: 8832185.
DOI: 10.1159/000521053.
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema.
Obis J, Arias L, Lorenzo D, Padron-Perez N, Garcia-Bru P, Cobos E
BMC Ophthalmol. 2021; 21(1):387.
PMID: 34740334
PMC: 8570006.
DOI: 10.1186/s12886-021-02132-w.
Current Management Options in Irvine-Gass Syndrome: A Systemized Review.
Orski M, Gawecki M
J Clin Med. 2021; 10(19).
PMID: 34640393
PMC: 8509495.
DOI: 10.3390/jcm10194375.
Fluorescein Angiography Findings in Eyes With Lamellar Macular Hole and Epiretinal Membrane Foveoschisis.
DellOmo R, Filippelli M, De Turris S, Cimino L, Steel D, Pavesio C
Invest Ophthalmol Vis Sci. 2021; 62(1):34.
PMID: 33512403
PMC: 7846948.
DOI: 10.1167/iovs.62.1.34.
A Review of Complicated Cataract in Retinitis Pigmentosa: Pathogenesis and Cataract Surgery.
Hong Y, Li H, Sun Y, Ji Y
J Ophthalmol. 2021; 2020:6699103.
PMID: 33489339
PMC: 7803180.
DOI: 10.1155/2020/6699103.
Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery.
Solomon K, Sandoval H, Potvin R
Clin Ophthalmol. 2020; 14:1959-1965.
PMID: 32764861
PMC: 7360419.
DOI: 10.2147/OPTH.S260926.
The Role of Subthreshold Micropulse Yellow Laser as an Alternative Option for the Treatment of Refractory Postoperative Cystoid Macular Edema.
Verdina T, DAloisio R, Lazzerini A, Ferrari C, Valerio E, Mastropasqua R
J Clin Med. 2020; 9(4).
PMID: 32283698
PMC: 7230455.
DOI: 10.3390/jcm9041066.
The Value and Caveats of Interpreting Small Case Series: Implications for Patient Care.
Parrish 2nd R, Chang T, Powers S
Am J Ophthalmol. 2019; 211:1-3.
PMID: 31697904
PMC: 6954668.
DOI: 10.1016/j.ajo.2019.10.027.
Comparison of topical nepafenac 0.1% with intravitreal dexamethasone implant for the treatment of Irvine-Gass syndrome.
Guclu H, Pelitli Gurlu V
Int J Ophthalmol. 2019; 12(2):258-267.
PMID: 30809482
PMC: 6376223.
DOI: 10.18240/ijo.2019.02.12.
